We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUAN
476
DELISTED
Nuance Communications, Inc.
NUAN
$7.43M 0.03%
648,417
-4,620
-0.7% -$64.7K
CCI icon
477
Crown Castle
CCI
$31.2B
$7.41M 0.03%
68,198
-5,218
-7% -$573K
HQY icon
478
HealthEquity
HQY
$7.98B
$7.39M 0.03%
123,921
+4,249
+4% +$343K
CB icon
479
Chubb
CB
$132B
$7.36M 0.03%
56,937
-8,728
-13% -$1.13M
AES icon
480
AES
AES
$10.6B
$7.32M 0.03%
506,066
+15,800
+3% +$237K
MPC icon
481
Marathon Petroleum
MPC
$115B
$7.29M 0.03%
123,555
+19,582
+19% +$1.34M
EAT icon
482
Brinker International
EAT
$8.5B
$7.29M 0.03%
165,660
-31,600
-16% -$1.5M
ALLY icon
483
Ally Financial
ALLY
$12.6B
$7.25M 0.03%
320,110
+170,900
+115% +$4.27M
TRU icon
484
TransUnion
TRU
$14.8B
$7.25M 0.03%
127,554
+58,000
+83% +$3.71M
APA icon
485
APA Corp
APA
$16.6B
$7.24M 0.03%
275,606
+233,174
+550% +$8.6M
ALLE icon
486
Allegion
ALLE
$13.1B
$7.22M 0.03%
90,603
+57,100
+170% +$4.93M
FANG icon
487
Diamondback Energy
FANG
$59.2B
$7.19M 0.03%
77,554
-39
-0.1% -$4.36K
CCL icon
488
Carnival Corporation Ltd
CCL
$30.3B
$7.18M 0.03%
145,694
-66,473
-31% -$3.81M
IDXX icon
489
Idexx Laboratories
IDXX
$40.2B
$7.16M 0.03%
38,471
+100
+0.3% +$20.5K
ALKS icon
490
Alkermes
ALKS
$7.72B
$7.15M 0.03%
242,295
-45,680
-16% -$1.68M
SBGI icon
491
Sinclair Inc
SBGI
$1.02B
$7.1M 0.03%
269,600
+88,300
+49% +$2.58M
VEA icon
492
Vanguard FTSE Developed Markets ETF
VEA
$234B
$7.08M 0.03%
190,900
UGI icon
493
UGI
UGI
$8.11B
$7.07M 0.03%
132,522
+21,100
+19% +$1.17M
SBRA icon
494
Sabra Healthcare REIT
SBRA
$5.18B
$6.99M 0.03%
423,846
+49,800
+13% +$1M
BLMN icon
495
Bloomin' Brands
BLMN
$686M
$6.98M 0.03%
390,000
-41,200
-10% -$812K
YUMC icon
496
Yum China
YUMC
$14.2B
$6.96M 0.03%
207,681
-81,958
-28% -$2.81M
BRKR icon
497
Bruker
BRKR
$8.49B
$6.95M 0.03%
233,400
+75,200
+48% +$2.37M
SLG icon
498
SL Green Realty
SLG
$3.67B
$6.93M 0.03%
90,571
-27,994
-24% -$2.48M
RLJ icon
499
RLJ Lodging Trust
RLJ
$1.67B
$6.9M 0.03%
420,621
-75,800
-15% -$1.47M
SIVB
500
DELISTED
SVB Financial Group
SIVB
$6.9M 0.03%
36,318
+4,400
+14% +$1.08M

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.